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A novel collagen IV chain, a4(IV), has recently been identified in basement membranes. We describe part of the primary structure of the human 
&4(IV) polypeptide for the first time, which has been determined by cloning and sequencing of cDNAs encoding 241 amino acid residues of the 
COL domain and 231 residues of the NC1 domain. We also characterized agenomic DNA fragment containing 4 exons coding for the entire NC1 
domain. Among five known a chains of collagen IV, the a4(IV) chain is distinct from the other four chains. However, it is more similar to the 
cc2 (IV) chain than to the al(IV), a3(IV) and aS(IV) chains in terms of amino acid sequence homology, domain structure of polypeptides and 
exon/intron structure of the genes, suggesting the presence of two phylogenetically distinct subclasses of collagen IV cc chains; one composed of 
u2 and a4 chains and the other of al, a3 and a5 chains. 
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1. INTRODUCTION 
Underlying most epithelium and endothelium is a 
thin, fuzzy layer and some fibrils that collectively make 
up the basement membrane. Constituents of the base- 
ment membrane have been shown to be made up of 
collagens, proteoglycans and other glycoproteins. Col- 
lagen IV is one of the major constituents of basement 
membranes [1,2]. It is a hetero or homotrimeric mole- 
cule containing three distinct domains: the 7S domain 
at the amino terminus, the central triple-helical(COL) 
domain and the NC1 domain located at the carboxyl 
terminus [2]. Recent techniques in protein chemistry 
[3-51 and molecular biology [6] have made it possible to 
permit unambiguous identification of new collagen 
chains present in high molecular aggregates in basement 
membranes. So far five distinct but related a chains: 
al(W), &2(W), a3(IV), cc4(IV) and a5(IV) have been 
designated as collagen IV chains due to their character- 
istic primary structure. Intriguingly, two sets of genes 
have been reported to co-localize in the same human 
chromosomal locus; al(W) gene(COL4Al) and a2 (IV) 
gene(COLAA2) sit on opposite strands on chromosome 
13q34, sharing a common promoter region 17-91 and 
human chromosome 2q36 is the region for both 
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a3(IV)(COL4A3) [lo] and a4(IV) collagen 
genes(COLAA4) [l 11. 
In this manuscript we report for the first time the 
primary structure of the 231 amino acid residues of the 
NC1 domain and the 241 residues of the COL domain 
of the human a4(IV) chain and the partial gene struc- 
ture of COL4A4. The exomintron structure of the 3’ 
part of the gene is similar to that of COL4A2 [12] but 
distinct from that of COL4Al [13], COL4A3 [14] and 
COL4A5 [15]. This suggests that the COL4A4 gene is 
phylogenetically related to COL4A2 gene rather than to 
the other three genes encoding the al(W), a3(IV) and 
a5(IV) chains. 
2. MATERIALS AND METHODS 
2.1. Cell culture and RNA blotting 
Cornea1 endothelial cells and lens epithelial cells were isolated from 
rabbit eyes and cultured as described [16]. Total cellular RNA was 
isolated from confluent cells with the guanidinium thiocyanate 
method [17]. Poly(A)’ RNA was isolated by oligo(dT)-cellulose 
chromatography. Total RNA extracted from human lung and kidney 
was kindly provided from Dr. Y. Muragaki, Wakayama Medical 
College. For Northern-blot analysis, RNAs were electrophoresed on 
1% agarose gels, blotted onto nylon titers, and hybridized with vari- 
ous probes using a standard method 1171. 28 S and 18 S ribosomal 
RNAs were used as size markers. 
2.2. cDNA cloning 
A jlgtl0 cDNA library (HLlO47a, Clontech Laboratories Inc.) from 
human whole eye was screened using the previously isolated cDNA, 
pYKb, coding for the rabbit a4(IV) chain [ll]. A few among 10 
positive clones were characterized as described below. Recombinant 
DNA isolation, filter hybridization and phage purification were per- 
formed as described [17]. 
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2.3. Screening of human genomic DNA 
A total genomic DNA library (HLlOO6d, Clontech Laboratories 
Inc.) was screened for human related genomic DNAs using a BarnHI/ 
EcoRI (476 bp) fragment of MS2 as a probe. Regular conditions were 
used for prehybridization and hybridization (5 x SSC, 1% N-laurylsar- 
cosine at 65”C, overnight) and for washing(3 x SSC, 0.5% N-lauryl- 
sarcosine at 65’C for 30 min, twice and 3 x SSC at 65°C for 30 min, 
twice) [16]. Isolation and purification of phage DNA was performed 
according to standard methods [17]. Restriction enzyme fragments of 
isolated clones were subcloned into pBluescript vectors for further 
characterization. 
2.4. Nucleotide sequence analysis 
Nucleotide sequencing was performed using the dideoxy chain ter- 
mination technique [18] using [“S]dATP and the Sequenase kit 
(United States Biochemicals, Cleveland, OH) either on double- 
stranded vectors [19] or on single-stranded Ml3 vectors [20]. Se- 
quence-specific oligonucleotides were used as primers when necessary. 
Some DNA fragments were deleted by exonuclease III and mung bean 
nuclease and self-ligated to the original vector using Kilo-Sequence 
Deletion kit (Takara Biochemicals, Kyoto, Japan). The nucleotide 
sequence from each strand was determined to confirm the data. The 
MacVector software was used to analyze the sequence data obtained. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of cDNAs encoding human a4(ZV) chain 
We have previously isolated and characterized 
cDNAs coding for the rabbit a4(IV) chain [l 11. One of 
the rabbit cDNAs, pYKb, was used to screen RgtlO 
cDNA libraries from whole eye for human 
a4(IV)cDNAs. As shown in Fig. 1, three cDNAs, MS2, 
MS3, and MS39 were isolated from the library. Com- 
plete nucleotide sequence analysis demonstrated that 
one reading frame remained open all through the in- 
sert( 1174 nucleotides) of the MS2 clone and the deduced 
amino acid sequence contained glycine residues in every 
third amino acid (Fig. 2), typical for collagenous pol- 
ypeptides. It encodes 241 residues of the triple-helical 
(COL) domain and 150 residues of the non-triple helical 
(NCl) domain. Identification of the clone was based 
upon complete identity between a part of the amino acid 
sequence deduced from the cDNA and the amino acid 
sequence from the junction of the COL and NC1 do- 
main of the cx4(IV) polypeptide [3,11]. This was also 
confirmed by a comparison with the amino acid se- 
quence from the coding region of an exon of the human 
ol4(IV) gene, COL4A4, located on chromosome 2 [l 11. 
3.2. a4(IV) transcript is larger than other collagen IV 
transcripts 
Unexpectedly, RNA species which specifically hy- 
bridized to the insert of the cDNA, MS2, were much 
larger than those hybridized to cDNAs coding for the 
other a-chains of collagen IV. As shown in Fig. 3, it 
hybridized to several species of RNA from human lung 
and kidney. The major two bands were approximately 
10 kb and 7 kb in size. a4(IV) mRNA is expressed more 
in kidney than in lung. A stretch of adenyl residues were 
found at the 3’ end of the two cDNAs, MS39 and MS3, 
indicating the presence of at least two different RNA 
transcripts, as found in other collagen mRNAs [21,22]. 
MS3 harbors a fairly long stretch (approximately 2 kb) 
of the 3’-untranslated region, which contains several 
poly(A) signals (Fig. 2). These signals could be utilized 
and generate several mRNA species. Although we do 
not know the structure of the 5’ two-thirds of the 
mRNA, the polypeptide encoded by the three cDNAs 
shown in Fig. 1 appears to be similar to the other four 
collagen IV chains. It would be interesting to know if 
the mRNA size difference is due to the longer amino 
terminal region or to the longer 5’-untranslated region 
for the a4(IV) transcript. 
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Fig. 1. Diagram representing the domain structure of the human @IV) collagen chain translation product as deduced from the nucleotide sequence 
of the cDNAs, MS2, MS39 and MS3, and the restriction enzyme maps of the clones. Closed squares above the a4(IV) domain structure indicate 
the location of the five imperfections of the Gly-X-Y triplet structure. Location of the cysteinyl residues are indicated by open circles. Note that 
the 5’ side of the MS39 (indicated by shadowing) is a copy of the intron; details are explained in section 3. 
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3.3. Primary structure of the human a4(IV) chain 
The composite nucleotide sequence of 3,559 bases 
from the overlapping 3 cDNAs of MS2, MS3 and MS39 
and its translation product are shown in Fig. 2. The 
translation product covered by the 3 cDNAs is not com- 
plete (see Fig. 1). The cDNAs encode 241 amino acid 
residues of the triple-helical (COL) domain, 231 resi- 
dues of the NC1 domain of the polypeptide of human 
a4(IV) chain and the 3’-untranslated region. The COL 
domain contains 72 Gly-X-Y triplets, 16 of which 22% 
are Gly-Pro-Pro triplets that stabilize collagen triple- 
helices, presumably utilizing hydroxyprolines located at 
Y positions. In the middle of the stretch of the triple- 
helical domain, a stretch of Gly-Pro-Pro repeated 4 
times was found. Five imperfections of Gly-X-Y repeats 
are found in the COL domain. Four cysteinyl residues 
124 
exist within COL domain: two of them (nucleotide num- 
bers 227-229 and 296298) are in the triple-helical do- 
main but the other two (numbers 470-472 and 566568) 
are within the two imperfections of the Gly-X-Y re- 
peats. None of the a chains of collagen IV contains 
cysteinyl residues within the COL domain in this region 
except for the a3 chain, which contains one cysteinyl 
residue in triple-helical domain [23] as shown in Fig. 4. 
The carboxyl-terminal non-triple-helical domain (NCl) 
for the a4(IV) chain contains 231 amino acid residues. 
When the other NC1 domains are compared as shown 
in Fig. 5, the total length is almost the same ranging 
from a maximum of 232 residues for a3 and a minimum 
of 227 residues for a2 . Twelve cysteinyl residues are 
aligned in position. When the a4(IV)NCl sequence was 
compared to other NC1 sequences, 60, 72, 54, and 60% 
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Fig. 3. Northern blot analysis of total RNA from human lung (lane 
1) and kidney (lane 2) with the a4(IV)-specific cDNA probe, MS2. 
Twenty fig of the total RNA was applied onto a 1% agarose gel, 
electrophoresed and blotted onto a nylon filter. 18 S and 28 S rRNAs 
were used as size markers as indicated. Note that a transcript of - 10 
kb is detected in lung and kidney. 
similarity was observed with al, a2, a3, and 
aS(IV)NCls, respectively. Among the five human NC1 
domains, higher homology was observed at both nucle- 
otide and amino acid levels between the a4 and a2 than 
between the a4 and al, a3 and a5NCls. When a4(IV) 
chains from rabbit, human, and bovine chains are com- 
pared with each other, they show a similar domain 
structure. 92 and 91% sequence similarity was obtained 
between human and rabbit [l l] and the human and 
bovine [24] NC1 domains at the amino acid level, re- 
spectively. 
3.4. Human a4(IV) genomic clone isolation 
A total human genomic library was screened by MS2 
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Fig. 5. Amino acid sequence comparison between the human a4(IV) 
NC1 domain and NC1 domains from four other human collagen IV 
a chains. Amino acid residues are numbered starting from the amino 
terminal end of the human a4(IV)NCl domain. The cDNA-deduced 
amino acid sequence of the human cz4QV)NCl (first row) domain is 
compared with the NC1 sequence from al(IV) (second row) [27], 
a2(IV) (third row) [28], a3(IV) (fourth row) [lo] and aS(IV) (fifth row) 
[29]. Dashes indicate that the amino acid sequence is the same as for 
the human a4(IV), otherwise the substituted residue is indicated. Gaps 
indicated by dots have been introduced to maintain alignment. Note 
that all the cysteinyl residues are conserved among the five a chains. 
to isolate the gene fragment for the a4(IV) chain. One 
of the three positive clones, YN14a (15 kb in size, shown 
in Fig. 6), was characterized further. An EcoRIISalI 
fragment of the YN14a clone was subcloned into 
pBluescript. The restriction enzyme digestion profile 
EPGDCGLPGPPGPPGPPGPPGYKGFPGCDGKDWKGPMGFPGPP 
GPHGFPGPPGEKGLPGPPGRKGPTGLPGPRGEPGPP 
~TV_P*_R___P__P_EI_p*____ 
DVDD~ RI LPGAPGNRGPEGANGLPGNRGPPGPG ~$&EPGLD~R~DGvPGsPG~PGRKGDTGEDGYP~PGPPGP 
-FM-NT--T-AV-DR--K-P--DP-F--AP-TV-A-GIAGI EPGFR A KA-pp RG - __ - -- -FR-DE-PI-HP-pI*R-A--R 
IGDPGPKGFG 
P-S--LP-MPGRS 
a1:VGFPGLAGSPGIPGSKGEPGFMGPPGPQGPPGLPGSPGH KGDRGPQGQPGLPGLPGPMGPPGLPGIDGVKGDKGNPGWPGAPGVPGPKGDPGFQGMPGIGGSPGITGSKGDMGPP 
~G_L--Ip_N__L__p___p__V-_P__V__p_-p_____p ~~~N~~___P_~R----__R__----_NG_I_~E---_-Q__L--L--L--_*-PP-L*-NP-R--LN-M---P-L- 
a3: 
GVPGFQGPKGLPGLPGIKGDQGDQGVPGAKGLPGPPGPPGP 
-----p-M--ps-Vp-sA-pE-EP-LI-PP-P_-LI~pp~p~_L~~~s~ 
-PP-PI-P--P--VR-D--T 
GLPGSMGPPGTP 
--o_pp__---s 
-KR-DS-S- 
Fig. 4. Amino acid sequence comparison in COL domains between a4(IV) and the other collagen IV. The amino acid residues in the COL domains 
are aligned to have best homology. Dashes indicate that the amino acid sequence is the same as for the top amino acid sequence; otherwise the 
substituted residue is indicated. The position of the imperfection of the Gly-X-Y are indicated by boxed areas. Note that the amino acid sequence 
of the cc4(IV) chain is similar to that of the a2 (IV) but different from that of the other three a(IV) chains with odd numbers, which have higher 
similarity in sequence among themselves. 
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Fig. 6. Diagram indicating the partial gene structure for the a4(IV) chain. The isolated genomic clone covers the four exons that are arbitrary 
designated counting from the 3’-end exon. Exon 2 encodes the 3’ part of the NC1 domain and part of the ~-unt~slated region (ingots by open 
box), whereas exon 3 codes for the middle part of the NC1 domain. Exons 4 and 5 are described in a previous report [I I]. Restriction sites are 
indicated by capital letters: E, EcoRI; H, HincII and S, Sufi (cloning site). 
and Southern-blot analysis together with nucleotide se- 
quence analysis demonstrated that the NC 1 domain was 
encoded by three separate exons: E2, E3 and E4 as 
shown in Fig. 6. 
We have previously reported [l l] that a genomic 
clone, YK3 1 (15 kb in size) contained two exons encod- 
ing a carboxyl part of the COL domain and the amino 
end of the NC1 domain. We isolated and characterized 
a new genomic fragment, YN14a, and discovered that 
the fragment was the same as before but that it con- 
tained two more exons located at the 3’ side of the 
previous exons. We renamed the numbers for these 
exons counting from the 3’ end as shown in Fig. 6. 
Sequences determined at the bounda~es between 
exons and introns follow the consensus rules with minor 
exceptions (Fig. 7). Exon 3 contains 95 complete codons 
and one split codon at the 5’ end. Exon 2 contains 87 
complete codons, a termination codon and 245 nucleo- 
tides of the 3’-untranslated region. The exonlintron 
structure of the c&IV) is similar to that of the (r2(IV) 
gene but quite different from that of the al(IV), a3(IV) 
and a5(IV) genes (Fig. 8). Positions of exon/intron 
boundaries with split codons are well conserved among 
the two subclasses of the genes shown in Fig. 8. The 
nucleotide sequence of the 5’ side of one of the cDNAs, 
MS 39, was different from that of MS2. It turned out 
to be the same as the sequence of the intron that was 
located at the 5’ side of exon 3, indicating that the 
cDNA was a copy of one of the premature RNA spe- 
cies. 
3.5. Which a chains of collagen IV cara constitute which 
collagen IV molecules? 
Collagen IV molecules, which were assumed to con- 
tain two al(IV) chains and one a2 (IV) chain, now also 
harbor a3(IV), @IV) and 05(1V) chains. Stoichiometry 
of collagen IV molecules could be different among tis- 
sues, suggesting the presence of subclass molecules of 
collagen IV with a unique chain composition. Recent 
analysis of the NC1 domains from the glomerular base- 
ment membranes uggested the existence of more than 
three different trimers: one composed of cll(IV)NCl 
and a2 (IV)NCl domains, a second composed of 
a3(IV)NCI and (114(1V)NCl, and a third with a mixed 
composition of all four a(IV)NCl subunits [25]. It has 
also been shown that a3(IV) and a4(IV) chains are co- 
Exon 3 
ccttcccaag (Q)GT CrG - . . . . . . . . . . . . . . . . . . . . . -rrc CYG ATG gtgagtcccs 
G L A F L ” 
Exon 2 
tt=WBtag u\c *(.a m . . . . . . . . . . . . ...*.*... T___EG ttgacggk& 
H T G 
Fig. 7. Nucleotide sequences of exon 2, exon 3, and neighboring introns. Capital letters indicate the exon sequences, and small letters are the intron 
sequences. Parenthesis indicates the split codons. 
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Fig. 8. Comparison of the exon structure located at the 3’ part of the collagen IV genes. Exons are indicated by boxes and introns by the 
interconnecting bars. Exons are numbered from the 3’ end. Numbers listed underneath each exon indicate nucleotide numbers of individual exons. 
When codons are split by the neighboring two exons, small letters ‘s’ are drawn between the two exons. Note that the two classes of genes are 
separated; one for a2 (IV) and a4(IV) genes, and the other for al(IV), a3(IV), and aS(IV) genes. 
localized and are only present in basement membranes 
in the kidney, eye, cochlea, lung, and brain, whereas the 
al(IV) and a2 (IV) chains are present in all basement 
membranes [26]. As shown in Figs. 4 and 5, sequence 
similarity among the five a chains of collagen IV and 
the locations of the imperfections within the triple-heli- 
cal domains together with a distinct gene structure sug- 
gest that there are two different subclasses of a chains: 
one composed of a2 and a4 chains, and a second with 
al, a3 and a5 chains. Theoretically these five chains can 
make up 35 different trimer molecules composed of 
unique chain combinations. The molecules can be con- 
nected in various arrangements and differ in distribu- 
tion in basement membranes of different tissues. We 
now know the primary structure of at least the NC1 
domains of all five a chains in human. The cloning of 
human a4(IV) cDNA provides a probe for molecular 
studies of human basement membrane diseases uch as 
autosomal forms of the Alport syndrome that may in- 
volve abnormalities in this a4 chain. It is also possible 
to raise chain-specific monoclonal antibodies that rec- 
ognize specific a chains to investigate the stoichiometry 
of collagen IV molecules and the tissue distribution of 
the molecules containing the a4(IV) chain. 
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